Showing results (1721-1730 of 2,011) with videos related to
Sort By:
Pageof 202
Water Science and Technology : a Journal of the International Association on Water Pollution Research|January 28, 2021
Nanostructured faujasite zeolite as metal ion adsorbent: kinetics, equilibrium adsorption and metal recovery studiesMariana B Goncalves, Djanyna V C Schmidt, Fabiana S Dos Santos, et al.Protoplasma|January 8, 2015
The effect of different concentrations of copper and lead on the morphology and physiology of Hypnea musciformis cultivated in vitro: a comparative analysisRodrigo W Santos, Éder C Schmidt, Izabela C Vieira, et al.Journal of the Pediatric Infectious Diseases Society|November 20, 2015
Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and ChildrenRuth A Karron, Jocelyn San Mateo, Bhagvanji Thumar, et al.NPJ Science of Food|April 9, 2022
Ultrafast cold-brewing of coffee by picosecond-pulsed laser extractionAnna R Ziefuß, Tim Hupfeld, Sven W Meckelmann, et al.Cancer Research|February 24, 1999
hMSH5: a human MutS homologue that forms a novel heterodimer with hMSH4 and is expressed during spermatogenesisT Bocker, A Barusevicius, T Snowden, et al.Journal of Crohn'S & Colitis|April 17, 2012
Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registryB Bokemeyer, J Hardt, D Hüppe, et al.Journal of Molecular Biology|July 13, 2000
Early evolution of cytochrome bc complexesM Schütz, M Brugna, E Lebrun, et al.Journal of Toxicology and Environmental Health. Part A|September 8, 2017
Investigation of full-scale ozonation at a municipal wastewater treatment plant using a toxicity-based evaluation conceptFabian Itzel, Linda Gehrmann, Helena Bielak, et al.Journal of Toxicology and Environmental Health. Part A|February 24, 2021
Effect-based evaluation of ozone treatment for removal of micropollutants and their transformation products in waste waterElke Dopp, Helena Pannekens, Anne Gottschlich, et al.Hematological Oncology|December 28, 2024
One-Day Brentuximab-Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin LymphomaH Moatti, P Brice, M-C Laroque, et al.Pageof 202